Sun Pharmaceutical industries share price has declined 4-5% in 2 trading sessions following OAI status determined by the ...

Sun Pharma said that the US FDA conducted an inspection at the company's Dadra facility from December 4, 2023 to December 15, 2023. The US FDA has subsequently determined the inspection ...

Sun Pharmaceutical Industries shares dropped 3.4 percent as the US FDA labelled its Dadra facility ... taking any investment decisions. Advisory Alert: It has come to our attention that certain ...

Dadra's specialization lies in the production of oral solid dosage forms and the manufacture of the blockbuster drug Revlimid, a vital revenue driver for Sun ... Advisory Alert: It has come ...

The Food and Drug Administration published an expanded import alert Wednesday to stop all plastic syringes made by a Chinese manufacturer from entering the U.S. On March 28, the FDA issued an ...

[Related: Taro announces merger agreement with Sun Pharma] At the meetings, Taro shareholders will be asked to consider and vote on the approval, pursuant to Section 320 of the Companies Law ...

The FDA has approved Amneal Pharmaceuticals’ ( NASDAQ: AMRX) OTC Naloxone HCl nasal spray, a generic version of the opioid ...

The government’s response to the COVID-19 pandemic opened the people’s eyes to the relentless power of pharmaceutical ...

Fluoxetine is used for the treatment of major depressive disorder, obsessive-compulsive disorder, bulimia nervosa and panic disorder, with or without agoraphobia. Strides’ wholly owned ...

A stock is considered to be oversold if the RSI reading falls below 30. In trading on Friday, shares of Royalty Pharma plc (Symbol: RPRX) entered into oversold territory, hitting an RSI reading of ...

The Sun Pharma's ordeal with the US drug regulator continues as its Halol Manufacturing facility in Gujarat is already under USFDA scanner facing import alert. Its Mohali unit also swaits USFDA ...